Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection

ConclusionsThe current study revealed that the median protective duration of ChAdOx1 and  BNT162b2 COVID-19 primary vaccination regimens administered in Saudi Arabia in 2021 was 134 days and that heterologous primary vaccination (ChAdOx1→BNT162b2) exhibited a significantly higher protective duration than other vaccination regimens.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research